| 1. |
Yin P, Wu JY, Wang LJ, et al. The burden of COPD in China and its provinces: findings from the Global Burden of Disease Study 2019. Front Public Health, 2022, 10: 859499.
|
| 2. |
叶志鹏, 陈磊. 慢性阻塞性肺疾病合并焦虑抑郁的研究进展. 中国呼吸与危重监护杂志, 2019, 18(5): 491-494.
|
| 3. |
Huang K, Huang KW, Xu JY, et al. Anxiety and depression in patients with chronic obstructive pulmonary disease in China: Results from the China Pulmonary Health [CPH] Study. Int J Chron Obstruct Pulmon Dis, 2021, 16: 3387-3396.
|
| 4. |
柯彩霞, 成守珍, 梁秀, 等. COPD病人焦虑、抑郁状况与社会支持的相关性研究. 全科护理, 2021, 19(12): 1684-1688.
|
| 5. |
留永健, 田欣伦, 郭兮恒, 等. 慢性阻塞性肺疾病合并焦虑抑郁患病调查. 中国呼吸与危重监护杂志, 2020, 19(5): 425-429.
|
| 6. |
Wrzeciono A, Czech O, Buchta K, et al. Assessment of stress, depressive and anxiety symptoms in patients with COPD during in-hospital pulmonary rehabilitation: an observational cohort study. Medicina (Kaunas), 2021, 57(3): 197.
|
| 7. |
Wu D, Zhao XN, Huang D, et al. Outcomes associated with comorbid anxiety and depression among patients with stable COPD: a patient registry study in China. J Affect Disord, 2022, 313: 77-83.
|
| 8. |
Hernández-Pérez A, Vargas-Núñez I, Moreno-Jiménez B, et al. Affective comorbidity associated with symptoms, lung function, and differences between patients with COPD for biomass and tobacco smoke exposure. J Clin Psychol Med Settings, 2022, 29(2): 310-317.
|
| 9. |
翟秋丽, 徐康, 李秀. 慢性阻塞性肺疾病患者合并焦虑的相关因素分析. 中国呼吸与危重监护杂志, 2020, 19(4): 393-397.
|
| 10. |
Yohannes AM, Murri MB, Hanania NA, et al. Depressive and anxiety symptoms in patients with COPD: a network analysis. Respir Med, 2022, 198: 106865.
|
| 11. |
方燕红, 刘兰芝. 慢性阻塞性肺疾病患者心理痛苦及相关影响因素. 中国健康心理学杂志, 2019, 27(9): 1370-1373.
|
| 12. |
Bülbüloğlu S, Kaplan Serin E. Effect of perceived dyspnea on attitude toward death from the perspective of COPD patients. Omega (Westport), 2023, 86(3): 913-929.
|
| 13. |
Bordoni B, Marelli F, Morabito B, et al. Depression, anxiety and chronic pain in patients with chronic obstructive pulmonary disease: the influence of breath. Monaldi Arch Chest Dis, 2017, 87(1): 811.
|
| 14. |
常旭. 慢阻肺合并焦虑、抑郁心理状态患者的血清生物标志物检验结果分析. 心理月刊, 2021, 16(4): 31-32.
|
| 15. |
Strollo HC, Nouraie SM, Hoth KF, et al. Association of systemic inflammation with depressive symptoms in individuals with COPD. Int J Chron Obstruct Pulmon Dis, 2021, 16: 2515-2522.
|
| 16. |
Milaneschi Y, Kappelmann N, Ye Z, et al. Association of inflammation with depression and anxiety: evidence for symptom-specificity and potential causality from UK Biobank and NESDA cohorts. Mol Psychiatry, 2021, 26(12): 7393-7402.
|
| 17. |
Borroto-Escuela DO, Ambrogini P, Chruścicka B, et al. The role of central serotonin neurons and 5-HT heteroreceptor complexes in the pathophysiology of depression: a historical perspective and future prospects. Int J Mol Sci, 2021, 22(4): 1927.
|
| 18. |
Margolis KG, Cryan JF, Mayer EA. The microbiota-gut-brain axis: from motility to mood. Gastroenterology, 2021, 160(5): 1486-1501.
|
| 19. |
Bhatt S, Devadoss T, Manjula SN, et al. 5-HT3 receptor antagonism a potential therapeutic approach for the treatment of depression and other disorders. Curr Neuropharmacol, 2021, 19(9): 1545-1559.
|
| 20. |
Bandelow B. Current and novel psychopharmacological drugs for anxiety disorders. Adv Exp Med Biol, 2020, 1191: 347-365.
|
| 21. |
Strawn JR, Levine A. Treatment response biomarkers in anxiety disorders: from neuroimaging to neuronally-derived extracellular vesicles and beyond. Biomark Neuropsychiatry, 2020, 3: 100024.
|
| 22. |
Kui HQ, Su HH, Wang Q, et al. Serum metabolomics study of anxiety disorder patients based on LC-MS. Clin Chim Acta, 2022, 533: 131-143.
|
| 23. |
李生霞. 心理护理干预对慢性阻塞性肺疾病伴呼吸衰竭患者的抑郁、焦虑缓解效果研究. 心理月刊, 2021, 16(4): 205-206.
|
| 24. |
Juruena MF, Eror F, Cleare AJ, et al. The role of early life stress in HPA axis and anxiety. Adv Exp Med Biol, 2020, 1191: 141-153.
|
| 25. |
Zhovanyk NV, Tovt-Korshynska MI. Interaction between clinical and psychological changes among patients with chronic obstructive pulmonary disease and pulmonary tuberculosis co-morbidity. Wiad Lek, 2019, 72(4): 635-638.
|
| 26. |
Aldhahi MI, Baattaiah BA, Nazer RI, et al. Impact of psychological factors on functional performance among patients with chronic obstructive pulmonary disease. Int J Environ Res Public Health, 2023, 20(2): 1285.
|
| 27. |
Fuentes-Alonso M, Lopez-Herranz M, López-de-Andrés A, et al. Prevalence and determinants of mental health among COPD patients in a population-based sample in Spain. J Clin Med, 2021, 10(13): 2786.
|
| 28. |
Wu DW, Chang LH, Yang PC, et al. Anxiety is a mediator between heart rate variability and quality of life in chronic obstructive pulmonary disease. J Pers Med, 2022, 12(6): 960.
|
| 29. |
Volpato E, Banfi P, Pagnini F. Promoting acceptance and adherence to noninvasive ventilation in chronic obstructive pulmonary disease: a randomized controlled trial. Psychosom Med, 2022, 84(4): 488-504.
|
| 30. |
Volpato E, Toniolo S, Pagnini F, et al. The relationship between anxiety, depression and treatment adherence in chronic obstructive pulmonary disease: a systematic review. Int J Chron Obstruct Pulmon Dis, 2021, 16: 2001-2021.
|
| 31. |
Lee SH, Lee H, Kim YS, et al. Predictors of low-level disease-specific knowledge in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis, 2020, 15: 1103-1110.
|
| 32. |
吴小玲. 艾司西酞普兰联合综合心理干预治疗慢性阻塞性肺疾病合并焦虑抑郁疗效观察. 现代中西医结合杂志, 2020, 29(14): 1522-1525.
|
| 33. |
屈蕾蕾, 胡杰亮, 刘丽君, 等. 帕罗西汀联合坦度螺酮治疗慢性阻塞性肺疾病合并焦虑与抑郁老年患者的临床研究. 中国临床药理学杂志, 2021, 37(13): 1641-1644.
|
| 34. |
卢平, 欧立文, 李牛秀, 等. 氟哌噻吨美利曲辛片联合沙美特罗替卡松治疗慢性阻塞性肺疾病并焦虑抑郁症的临床疗效及其对炎性因子的影响. 临床合理用药杂志, 2021, 14(9): 94-96.
|
| 35. |
Yang S, Xu Y, Peng WP, et al. Chinese herbal medicine for symptoms of depression and anxiety in chronic obstructive pulmonary disease: a systematic review and meta-analysis. Complement Ther Clin Pract, 2021, 45: 101470.
|
| 36. |
Fei F, J Siegert R, Zhang XH, et al. Symptom clusters, associated factors and health-related quality of life in patients with chronic obstructive pulmonary disease: a structural equation modelling analysis. J Clin Nurs, 2023, 32(1-2): 298-310.
|
| 37. |
Hart JL, Hong D, Summer A, et al. Stakeholders' views on reducing psychological distress in chronic obstructive pulmonary disease. J Pain Symptom Manage, 2022, 63(1): e21-e28.
|
| 38. |
Zhang XM, Yin CC, Tian WG, et al. Effects of cognitive behavioral therapy on anxiety and depression in patients with chronic obstructive pulmonary disease: a meta-analysis and systematic review. Clin Respir J, 2020, 14(10): 891-900.
|
| 39. |
Sohanpal R, Pinnock H, Steed L, et al. Tailored, psychological intervention for anxiety or depression in people with chronic obstructive pulmonary disease (COPD), TANDEM (Tailored intervention for ANxiety and DEpression Management in COPD): protocol for a randomised controlled trial. Trials, 2020, 21(1): 18.
|
| 40. |
冯梅, 何颖, 袁敏, 等. 聚焦式心理干预在慢性阻塞性肺病(COPD)合并2型呼吸衰竭患者中的应用效果. 中国健康心理学杂志, 2023, 31(1): 53-58.
|
| 41. |
唐静, 张凯莉, 崔君, 等. 健康教育对慢性阻塞性肺病患者情绪、不良认知及社会功能的影响. 国际精神病学杂志, 2020, 47(2): 393-395, 403.
|
| 42. |
张彩丽, 单海娟. 标准化心理干预对慢性阻塞性肺疾病患者自我感受负担、负性情绪及生活质量的影响. 中国健康心理学杂志, 2021, 29(9): 1341-1344.
|
| 43. |
Zhang YT, Zhao XF. Effects of the health belief model-based intervention on anxiety, depression, and quality of life in chronic obstructive pulmonary disease. Neuroimmunomodulation, 2021, 28(3): 129-136.
|
| 44. |
Giusti EM, Papazian B, Manna C, et al. The effects of an acceptance and commitment-informed interdisciplinary rehabilitation program for chronic airway diseases on health status and psychological symptoms. Front Psychol, 2022, 12: 818659.
|
| 45. |
朱海敏, 陈冠彬, 刘业辉, 等. 歌唱疗法作为慢性阻塞性肺疾病的康复手段在基层医院中的应用. 内蒙古医学杂志, 2020, 52(7): 807-809.
|
| 46. |
Lewis A, Philip KEJ, Lound A, et al. The physiology of singing and implications for 'Singing for Lung Health' as a therapy for individuals with chronic obstructive pulmonary disease. BMJ Open Respir Res, 2021, 8(1): e000996.
|
| 47. |
Huang J, Yuan XH, Zhang N, et al. Music therapy in adults with COPD. Respir Care, 2021, 66(3): 501-509.
|
| 48. |
沈菊凤, 侯雪芬, 刘春霞. 中医情志护理干预对心肌梗死患者心理状态的影响. 新中医, 2021, 53(17): 188-190.
|
1/5
WeChat